Grufity logoGrufity logo
StocksFundsSearch FilingsAPI

Enovis CORP Stock Research

ENOV

51.65USD-0.23(-0.44%)Market Closed
Watchlist

Market Summary

USD51.65-0.23
Market Closed
-0.44%

ENOV Stock Price

ENOV RSI Chart

ENOV Valuation

ENOV Profitability

ENOV Fundamentals

Price Action

52 Week Range

43.8866.14
(Low)(High)

Last 7 days

-3%

Last 30 days

-7.4%

Last 90 days

-13.7%

Trailing 12 Months

4.8%

ENOV Financial Health

ENOV Investor Care

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Latest Insider Trading transactions for ENOV

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
2023-08-07
KLECKNER JOHN
sold
-10,297
59.18
-174
principal accounting officer
2023-07-20
KLECKNER JOHN
sold
-4,376
65.32
-67.00
principal accounting officer
2023-06-30
Lalor Angela S
acquired
-
-
313
-
2023-06-02
BERRY PHILLIP BENJAMIN (BEN)
sold
-34,939
54.17
-645
svp, chief financial officer
2023-05-16
Wienbar Sharon L
acquired
-
-
1,875
-
2023-05-16
Ortiz Christine
acquired
-
-
1,875
-
2023-05-16
Bodem Barbara W.
acquired
-
-
1,875
-
2023-05-16
PERFALL A CLAYTON
acquired
-
-
1,875
-
2023-05-16
Okala Philip
acquired
-
-
1,875
-
2023-05-16
Lalor Angela S
acquired
-
-
1,875
-

1–10 of 50

Which funds bought or sold ENOV recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
2023-09-20
BARCLAYS PLC
added
11.28
1,477,000
5,902,000
-%
2023-08-23
WOLVERINE TRADING, LLC
new
-
618,447
618,447
-%
2023-08-22
VIRGINIA RETIREMENT SYSTEMS ET AL
reduced
-23.73
-135,255
1,442,700
0.01%
2023-08-21
OSAIC HOLDINGS, INC.
added
341
354,286
436,861
-%
2023-08-21
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-1.64
591,726
3,895,480
0.01%
2023-08-21
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
added
11.23
139,000
554,000
-%
2023-08-17
Durable Capital Partners LP
reduced
-43.88
-47,514,700
97,658,900
0.86%
2023-08-16
Broadcrest Asset Management, LLC
sold off
-100
-18,721,500
-
-%
2023-08-16
Nuveen Asset Management, LLC
added
36.65
9,380,430
24,079,400
0.01%
2023-08-15
Cornerstone Planning Group LLC
new
-
3,398
3,398
-%

1–10 of 48

Latest Funds Activity

Are funds buying ENOV calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own ENOV
No. of Funds

Schedule 13G FIlings of Enovis

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2023
t. rowe price investment management, inc.
11.2%
6,040,170
SC 13G/A
Feb 13, 2023
rales mitchell p
3.3%
1,798,851
SC 13G/A
Feb 13, 2023
durable capital partners lp
5.0%
2,714,032
SC 13G/A
Feb 09, 2023
vanguard group inc
8.45%
4,574,286
SC 13G/A
Jan 25, 2023
blackrock inc.
9.1%
4,932,356
SC 13G
Sep 20, 2022
rales steven m
4.9%
2,645,578
SC 13G/A

Recent SEC filings of Enovis

View All Filings
Date Filed Form Type Document
Sep 12, 2023
8-K
Current Report
Aug 07, 2023
4
Insider Trading
Aug 03, 2023
8-K
Current Report
Aug 03, 2023
10-Q
Quarterly Report
Jul 20, 2023
4
Insider Trading
Jul 03, 2023
4
Insider Trading
Jun 29, 2023
11-K
Employee Benefit Details

Enovis News

Seeking Alpha
Enovis to acquire orthopedic company Lima in €800 million cash ....
Seeking Alpha,
12 minutes ago
MarketWatch
StreetInsider.com
Insider Monkey
Hedge Fund Investor Letters Q2 2023.
Insider Monkey,
3 days ago
Marketscreener.com
StreetInsider.com
Form N-PX HOMESTEAD FUNDS INC For: Jun 30.
StreetInsider.com,
27 days ago
Seeking Alpha
Seeking Alpha

Returns for ENOV

Cumulative Returns on ENOV

-0.8%


10-Year Cumulative Returns

8.4%


7-Year Cumulative Returns

7.2%


5-Year Cumulative Returns

19.1%


3-Year Cumulative Returns

Risks for ENOV

What is the probability of a big loss on ENOV?

84.6%


Probability that Enovis stock will be more than 20% underwater in next one year

65%


Probability that Enovis stock will be more than 30% underwater in next one year.

36.5%


Probability that Enovis stock will be more than 40% underwater in next one year.
*Calculated based on probability distribution of losses observed in actual data in the last 5 years.

How does ENOV drawdown profile look like?

Y-axis is the maximum loss one would have experienced if Enovis was unfortunately bought at previous high price.

Drawdowns

Financials for Enovis

ENOV Income Statement

2023-06-30
CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($)
$ in Thousands
3 Months Ended6 Months Ended
Jun. 30, 2023
Jul. 01, 2022
Jun. 30, 2023
Jul. 01, 2022
Income Statement [Abstract]    
Net sales$ 428,502$ 395,117$ 834,653$ 770,574
Cost of sales180,143179,211351,229348,768
Gross profit248,359215,906483,424421,806
Selling, general and administrative expense207,881193,657415,046382,137
Research and development expense18,91815,66137,11130,503
Amortization of acquired intangibles32,24931,82464,28962,610
Insurance settlement gain0(33,034)0(33,034)
Restructuring and other charges3,8052,2456,4404,664
Operating income (loss)(14,494)5,553(39,462)(25,074)
Interest expense, net4,0764,5469,72811,610
Debt extinguishment charges020,104020,104
Unrealized gain on investment in ESAB Corporation0(135,537)0(135,537)
Other expense, net7530920
Income (loss) from continuing operations before income taxes(19,323)116,440(49,282)78,749
Income tax benefit(4,713)(4,211)(11,826)(3,847)
Net income (loss) from continuing operations(14,610)120,651(37,456)82,596
Income (loss) from discontinued operations, net of taxes4,797(43,666)4,48510,690
Net income (loss)(9,813)76,985(32,971)93,286
Less: net income attributable to noncontrolling interest from continuing operations - net of taxes182130374397
Less: net income attributable to noncontrolling interest from discontinued operations - net of taxes000966
Net income (loss) attributable to Enovis Corporation$ (9,995)$ 76,855$ (33,345)$ 91,923
Net income (loss) per share - basic    
Net income (loss) per share, continuing operations, basic (in usd per share)$ (0.27)$ 2.23$ (0.70)$ 1.52
Net income (loss) per share, discontinued operations, basic (in usd per share)0.09(0.81)0.080.18
Net income (loss) per share, consolidated, basic (in usd per share) 1.42(0.61)1.70
Net income (loss) per share, continuing operations, diluted (in usd per share)(0.27)2.21(0.70)1.51
Net income (loss) per share, discontinued operations, diluted (in usd per share)0.09(0.80)0.080.18
Net income (loss) per share, consolidated operations, (in usd per share)$ (0.18)$ 1.41$ (0.61)$ 1.69

ENOV Balance Sheet

2023-06-30
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Jun. 30, 2023
Dec. 31, 2022
ASSETS  
Cash and cash equivalents$ 32,491$ 24,295
Trade receivable, less allowance for credit losses298,976267,380
Inventories, net453,897426,643
Prepaid expenses26,75828,550
Other current assets75,11748,155
Total current assets887,239795,023
Property, plant and equipment, net260,754236,741
Goodwill2,034,0871,983,588
Intangible assets, net1,110,9501,110,727
Lease asset - right of use61,73966,881
Other assets88,78480,288
Total assets4,443,5534,273,248
LIABILITIES AND EQUITY  
Current portion of long-term debt0219,279
Accounts payable147,180135,628
Accrued liabilities206,493210,292
Total current liabilities353,673565,199
Long-term debt, less current portion400,00040,000
Non-current lease liability47,56751,259
Other liabilities191,553166,989
Total liabilities992,793823,447
Equity:  
Common stock, $0.001 par value; 133,333,333 shares authorized; 54,534,111 and 54,228,619 shares issued and outstanding as of June 30, 2023 and December 31, 2022, respectively5554
Additional paid-in capital2,944,0942,925,729
Retained earnings542,387575,732
Accumulated other comprehensive loss(37,898)(53,430)
Total Enovis Corporation equity3,448,6383,448,085
Noncontrolling interest2,1221,716
Total equity3,450,7603,449,801
Total liabilities and equity$ 4,443,553$ 4,273,248
Matthew L. Trerotola
16200
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries. It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger. Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand. The company was formerly known as Colfax Corporation. Enovis Corporation is headquartered in Wilmington, Delaware.